PUBLISHER: BIS Research | PRODUCT CODE: 1811800
PUBLISHER: BIS Research | PRODUCT CODE: 1811800
Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application, Country, and Region - Analysis and Forecast, 2025-2035
Global Biobanking Market, Analysis and Forecast: 2025-2035
Biobanking refers to the process of collecting, storing, and managing biological samples (such as blood, tissue, DNA, RNA, and other bodily fluids) for research and medical purposes. These samples are preserved and catalogued in biorepositories or biobanks, where they are stored under controlled conditions to maintain their integrity for long-term use. Biobanks are invaluable resources for scientific research, particularly in fields like genomics, cancer research, drug development, and epidemiology.
Researchers use biobanks to investigate the genetic and environmental factors that contribute to diseases, understand disease mechanisms, and develop personalized treatments. Biobanks are also used for testing the efficacy of new medications, understanding population health trends, and advancing medical knowledge. With the growing focus on precision medicine, biobanks are becoming increasingly important as they provide high-quality biological samples that are essential for creating tailored healthcare solutions based on individual genetic profiles.
One of the key drivers of the biobanking market is the increasing demand for personalized medicine. As advancements in genomics and biotechnology continue to progress, there is a growing focus on tailoring medical treatments to individual patients based on their genetic makeup. Biobanks play a critical role in this area by storing diverse biological samples that can be used to understand genetic variations and their implications on health and disease. These samples help researchers develop targeted therapies and treatments that are more effective and less harmful to patients.
The rise in chronic diseases, such as cancer, diabetes, and cardiovascular conditions, further drives the need for biobanks. By providing a repository of biological materials, biobanks enable researchers to identify disease biomarkers, understand disease mechanisms, and develop new diagnostic and therapeutic methods. As personalized medicine becomes a central pillar of modern healthcare, the demand for biobanks and high-quality biological samples is expected to continue to grow.
Despite the growth of the biobanking market, several challenges persist. One of the primary challenges is the ethical and legal concerns associated with the collection, storage, and use of biological samples. Issues surrounding informed consent, privacy, and confidentiality of donor information remain a significant challenge. Ensuring that individuals provide informed consent for the use of their biological samples in research and that their privacy is protected is crucial, especially when dealing with sensitive genetic data.
Furthermore, the lack of uniform regulations and standardization in biobanking practices across different regions and institutions can lead to discrepancies in data quality, sample handling, and storage methods. This lack of standardization complicates data sharing and collaboration among research institutions, which can limit the global utility of biobank resources.
Lastly, there are financial, and infrastructure challenges related to maintaining biobanks, as they require significant investment in both the physical infrastructure (such as storage facilities) and technology to manage vast amounts of data and biological samples over extended periods.
The global Biobanking market is highly competitive, with major players such as Becton, Dickinson and Company, QIAGEN N.V., Merck KGaA, Thermo Fisher Scientific Inc., PHC Holdings Corporation, Cryoport, Inc., Azenta, Inc., Avantor, Inc., Tecan Trading AG, Greiner AG, Bay Biosciences LLC, Shanghai Zhangjiang Biobank, US Biolab Corporation, Inc., Cureline, and Brooks Life Sciences leading the way. These companies are continuously innovating and expanding their product portfolios to cater to the growing demand for biological sample storage, processing, and management in research, personalized medicine, and drug development.
The competition in the market is driven by advancements in technology, improvements in storage capabilities, and the increasing need for high-quality biological samples for clinical trials, genomic research, and disease study. With significant investments in infrastructure, digitalization, and regulatory compliance, these key players are well-positioned to shape the future of the biobanking market.
Biobanking Market Segmentation:
Segmentation 1: by Product and Service
- Equipment
- Storage Equipment
- Sample Analysis Equipment
- Sample Processing Equipment
- Sample Transport Equipment
- Consumables
- Storage Consumables
- Analysis Consumables
- Processing Consumables
- Collection Consumables
- Services
- Storage Services
- Processing Services
- Transport Services
- Supply Services
- Software
Segmentation 2: by Storage Type
- Manual Storage
- Automated Storage
Segmentation 3: by Sample Type
- Blood Products
- Human Tissues
- Cell Lines
- Nucleic Acids
- Biological Fluids
- Human Waste Products
Segmentation 4: by Ownership
- Universities
- National/Regional Agencies
- Non-Profit Organizations
- Private Organizations
Segmentation 5: by Biobank Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population-Based Biobanks
- Genetic (DNA/RNA)
- Disease-Based Biobanks
- Virtual Biobanks
Segmentation 6: by Application
- Regenerative Medicine
- Life Science Research
- Clinical Research
Segmentation 7: by End User
- Pharmaceutical & Biotechnology Companies and Cros
- Academic And Research Institutes
- Hospitals
Segmentation 8: by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
One of the most significant emerging trends in the global biobanking market is the integration of digital technologies and automation. This trend involves the adoption of advanced data management systems, AI-driven platforms, and automation in sample collection, storage, and analysis. These technologies improve the efficiency, accuracy, and scalability of biobanking operations, making it easier to manage large volumes of biological samples. Automation helps streamline processes, reduces human error, and enhances the reliability of sample handling, which is crucial for maintaining sample integrity.
Moreover, digital tools enable better tracking and management of samples across different research facilities and regions, promoting more efficient data sharing and collaboration between global biobank networks. With the growing demand for high-quality and well-organized biological samples, this trend is expected to continue to shape the biobanking industry, supporting advancements in personalized medicine, genomics, and drug development.
Table of Contents
Executive Summary
Scope and Definition
Market/Product Definition
Inclusion and Exclusion
Key Questions Answered
Analysis and Forecast Note
1. Global Biobanking Market: Industry Outlook
- 1.1 Introduction
- 1.2 Market Trends
- 1.3 Regulatory Framework
- 1.4 Case Studies
- 1.5 Product Benchmarking
- 1.6 Market Dynamics
- 1.6.1 Impact Analysis
- 1.6.2 Market Drivers
- 1.6.3 Market Challenges
- 1.6.4 Market Opportunities
2. Global Biobanking Market (by Product and Service), ($Billion), 2024-2035
- 2.1 Equipment
- 2.1.1 Storage Equipment
- 2.1.2 Sample Analysis Equipment
- 2.1.3 Sample Processing Equipment
- 2.1.4 Sample Transport Equipment
- 2.2 Consumables
- 2.2.1 Storage Consumables
- 2.2.2 Analysis Consumables
- 2.2.3 Processing Consumables
- 2.2.4 Collection Consumables
- 2.3 Services
- 2.3.1 Storage Services
- 2.3.2 Processing Services
- 2.3.3 Transport Services
- 2.3.4 Supply Services
- 2.4 Software
3. Global Biobanking Market (by Storage Type), ($Billion), 2024-2035
- 3.1 Manual Storage
- 3.2 Automated Storage
4. Global Biobanking Market (by Sample Type), ($Billion), 2024-2035
- 4.1 Blood Products
- 4.2 Human Tissues
- 4.3 Cell Lines
- 4.4 Nucleic Acids
- 4.5 Biological Fluids
- 4.6 Human Waste Products
5. Global Biobanking Market (by Ownership), ($Billion), 2024-2035
- 5.1 Universities
- 5.2 National/Regional Agencies
- 5.3 Non-Profit Organizations
- 5.4 Private Organizations
6. Global Biobanking Market (by Biobank Type), ($Billion), 2024-2035
- 6.1 Physical/Real Biobanks
- 6.2 Tissue Biobanks
- 6.3 Population-Based Biobanks
- 6.4 Genetic (DNA/RNA)
- 6.5 Disease-Based Biobanks
- 6.6 Virtual Biobanks
7. Global Biobanking Market (by Application), ($Billion), 2024-2035
- 7.1 Regenerative Medicine
- 7.2 Life Science Research
- 7.3 Clinical Research
8. Global Biobanking Market (by End User), ($Billion), 2024-2035
- 8.1 Pharmaceutical & Biotechnology Companies and Cros
- 8.2 Academic And Research Institutes
- 8.3 Hospitals
9. Global Biobanking Market (by Region), ($Billion), 2024-2035
- 9.1 North America
- 9.1.1 Key Findings
- 9.1.2 Market Dynamics
- 9.1.3 Market Sizing and Forecast
- 9.1.3.1 North America Biobanking Market, by Country
- 9.1.3.1.1 U.S.
- 9.1.3.1.2 Canada
- 9.1.3.1 North America Biobanking Market, by Country
- 9.2 Europe
- 9.2.1 Key Findings
- 9.2.2 Market Dynamics
- 9.2.3 Market Sizing and Forecast
- 9.2.3.1 Europe Biobanking Market, by Country
- 9.2.3.1.1 Germany
- 9.2.3.1.2 U.K.
- 9.2.3.1.3 France
- 9.2.3.1.4 Italy
- 9.2.3.1.5 Spain
- 9.2.3.1.6 Rest of the Europe
- 9.2.3.1 Europe Biobanking Market, by Country
- 9.3 Asia Pacific
- 9.3.1 Key Findings
- 9.3.2 Market Dynamics
- 9.3.3 Market Sizing and Forecast
- 9.3.3.1 Asia Pacific Biobanking Market, by Country
- 9.3.3.1.1 China
- 9.3.3.1.2 Japan
- 9.3.3.1.3 India
- 9.3.3.1.4 Australia
- 9.3.3.1.5 Rest of Asia Pacific
- 9.3.3.1 Asia Pacific Biobanking Market, by Country
- 9.4 Rest of the World
- 9.4.1 Key Findings
- 9.4.2 Market Dynamics
- 9.4.3 Market Sizing and Forecast
10. Global Biobanking Market: Competitive Landscape and Company Profiles
- 10.1 Key Strategies and Development
- 10.1.1 Mergers and Acquisitions
- 10.1.2 Synergistic Activities
- 10.1.3 Business Expansions and Funding
- 10.1.4 Product Launches and Approvals
- 10.1.5 Other Activities
- 10.2 Company Profiles
- 10.2.1 Becton, Dickinson and Company
- 10.2.1.1 Overview
- 10.2.1.2 Top Products / Product Portfolio
- 10.2.1.3 Top Competitors
- 10.2.1.4 Target Customers/End-Users
- 10.2.1.5 Key Personnel
- 10.2.1.6 Analyst View
- 10.2.2 QIAGEN N.V.
- 10.2.2.1 Overview
- 10.2.2.2 Top Products / Product Portfolio
- 10.2.2.3 Top Competitors
- 10.2.2.4 Target Customers/End-Users
- 10.2.2.5 Key Personnel
- 10.2.2.6 Analyst View
- 10.2.3 Merck KGaA
- 10.2.3.1 Overview
- 10.2.3.2 Top Products / Product Portfolio
- 10.2.3.3 Top Competitors
- 10.2.3.4 Target Customers/End-Users
- 10.2.3.5 Key Personnel
- 10.2.3.6 Analyst View
- 10.2.4 Thermo Fisher Scientific Inc.
- 10.2.4.1 Overview
- 10.2.4.2 Top Products / Product Portfolio
- 10.2.4.3 Top Competitors
- 10.2.4.4 Target Customers/End-Users
- 10.2.4.5 Key Personnel
- 10.2.4.6 Analyst View
- 10.2.5 PHC Holdings Corporation
- 10.2.5.1 Overview
- 10.2.5.2 Top Products / Product Portfolio
- 10.2.5.3 Top Competitors
- 10.2.5.4 Target Customers/End-Users
- 10.2.5.5 Key Personnel
- 10.2.5.6 Analyst View
- 10.2.6 Cryoport, Inc.
- 10.2.6.1 Overview
- 10.2.6.2 Top Products / Product Portfolio
- 10.2.6.3 Top Competitors
- 10.2.6.4 Target Customers/End-Users
- 10.2.6.5 Key Personnel
- 10.2.6.6 Analyst View
- 10.2.7 Azenta, Inc.
- 10.2.7.1 Overview
- 10.2.7.2 Top Products / Product Portfolio
- 10.2.7.3 Top Competitors
- 10.2.7.4 Target Customers/End-Users
- 10.2.7.5 Key Personnel
- 10.2.7.6 Analyst View
- 10.2.8 Avantor, Inc.
- 10.2.8.1 Overview
- 10.2.8.2 Top Products / Product Portfolio
- 10.2.8.3 Top Competitors
- 10.2.8.4 Target Customers/End-Users
- 10.2.8.5 Key Personnel
- 10.2.8.6 Analyst View
- 10.2.9 Tecan Trading AG
- 10.2.9.1 Overview
- 10.2.9.2 Top Products / Product Portfolio
- 10.2.9.3 Top Competitors
- 10.2.9.4 Target Customers/End-Users
- 10.2.9.5 Key Personnel
- 10.2.9.6 Analyst View
- 10.2.10 Greiner AG
- 10.2.10.1 Overview
- 10.2.10.2 Top Products / Product Portfolio
- 10.2.10.3 Top Competitors
- 10.2.10.4 Target Customers/End-Users
- 10.2.10.5 Key Personnel
- 10.2.10.6 Analyst View
- 10.2.11 Bay Biosciences LLC
- 10.2.11.1 Overview
- 10.2.11.2 Top Products / Product Portfolio
- 10.2.11.3 Top Competitors
- 10.2.11.4 Target Customers/End-Users
- 10.2.11.5 Key Personnel
- 10.2.11.6 Analyst View
- 10.2.12 Shanghai Zhangjiang Biobank
- 10.2.12.1 Overview
- 10.2.12.2 Top Products / Product Portfolio
- 10.2.12.3 Top Competitors
- 10.2.12.4 Target Customers/End-Users
- 10.2.12.5 Key Personnel
- 10.2.12.6 Analyst View
- 10.2.13 US Biolab Corporation, Inc.
- 10.2.13.1 Overview
- 10.2.13.2 Top Products / Product Portfolio
- 10.2.13.3 Top Competitors
- 10.2.13.4 Target Customers/End-Users
- 10.2.13.5 Key Personnel
- 10.2.13.6 Analyst View
- 10.2.14 Cureline
- 10.2.14.1 Overview
- 10.2.14.2 Top Products / Product Portfolio
- 10.2.14.3 Top Competitors
- 10.2.14.4 Target Customers/End-Users
- 10.2.14.5 Key Personnel
- 10.2.14.6 Analyst View
- 10.2.15 Brooks Life Sciences
- 10.2.15.1 Overview
- 10.2.15.2 Top Products / Product Portfolio
- 10.2.15.3 Top Competitors
- 10.2.15.4 Target Customers/End-Users
- 10.2.15.5 Key Personnel
- 10.2.15.6 Analyst View
- 10.2.1 Becton, Dickinson and Company
11. Research Methodology
List of Figures
- Figure: Global Biobanking Market (by Product and Service), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Storage Type), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Sample Type), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Ownership), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Biobank Type), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Application), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by End User), $Billion, 2024 and 2035
- Figure: Global Biobanking Market (by Region), $Billion, 2024 and 2035
- Figure: Global Biobanking Market Key Trends, Analysis
List of Tables
- Table: Global Biobanking Market Dynamics, Impact Analysis
- Table: Global Biobanking Market (by Region), $Billion, 2024-2035
